Showing results (1621-1630 of 1,703) with videos related to
Sort By:
Pageof 171
Emerging Microbes & Infections|November 5, 2021
Waning antibodies from inactivated SARS-CoV-2 vaccination offer protection against infection without antibody-enhanced immunopathology in rhesus macaque pneumonia modelsDandan Li, Ning Luan, Jing Li, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 17, 2024
Suppressing UBE2N ameliorates Alzheimer's disease pathology through the clearance of amyloid betaChen Zhang, Qingqing Jia, Longhong Zhu, et al.Future Oncology (London, England)|March 31, 2022
Phase I/Ib dose-escalation study of avelumab in Chinese patients with advanced solid tumorsYi-Long Wu, Ying Cheng, Huajun Chen, et al.Human Brain Mapping|January 22, 2019
Classification of schizophrenia by intersubject correlation in functional connectomeGong-Jun Ji, Xingui Chen, Tongjian Bai, et al.Environmental Science & Technology|May 20, 2022
Field Detection of Highly Oxygenated Organic Molecules in Shanghai by Chemical Ionization-OrbitrapYanjun Zhang, Dandan Li, Yingge Ma, et al.Journal of Proteomics|April 30, 2022
Identification of lysine acetylome of oral squamous cell carcinoma by label-free quantitative proteomicsJingjing Dong, Jingquan He, Zeyu Zhang, et al.Journal of Pharmaceutical and Biomedical Analysis|January 14, 2020
LC-MS/MS assay coupled with carboxylic acid magnetic bead affinity capture to quantitatively measure cationic host defense peptides (HDPs) in complex matrices with application to preclinical pharmacokinetic studiesMaura J O'Neill, King Chan, Jesse M Jaynes, et al.BMC Veterinary Research|May 19, 2026
Epidemiological and genetic variation analysis of emerging porcine circovirus type 3 in Henan Province, 2023-2024Jiajing Song, Hongyue Zhai, Jiajia Cao, et al.Plos One|July 22, 2015
Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Intermediate-Risk Acute Myeloid Leukemia Adult Patients in First Complete Remission: A Meta-Analysis of Prospective StudiesDandan Li, Li Wang, Honghu Zhu, et al.Medcomm|February 19, 2025
Addition of anti-PD-1 immunotherapy to BRAF inhibitor-based targeted therapy improves real-world survival and delays brain metastases in patients with BRAFV600-mutant advanced melanoma: a multicenter cohort studyJunwan Wu, Qiuyue Ding, Qiong Zhang, et al.Pageof 171